FDA Approved: MODAFINIL — Supplemental Application (CIMA LABS INC.)

View source ↗

Summary

FDA approved a supplemental application for modafinil submitted by CIMA Labs, resulting in changes to the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea-hypopnea Syndrome
• Shift Work Sleep Disorder

Drugs mentioned

• Modafinil (modafinil)

Snippet

SUPPL AP for MODAFINIL (MODAFINIL)